In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Parke Davis Brand of Amitriptyline Hydrochloride Drug Master File in Korea (Parke Davis Brand of Amitriptyline Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Parke Davis Brand of Amitriptyline Hydrochloride. The MFDS reviews the Parke Davis Brand of Amitriptyline Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Parke Davis Brand of Amitriptyline Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Parke Davis Brand of Amitriptyline Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Parke Davis Brand of Amitriptyline Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Parke Davis Brand of Amitriptyline Hydrochloride suppliers with KDMF on PharmaCompass.